Two instances where independent research makes the difference

It is a fact that subscription-based research delivers a service where brokers capitulate.

Consider 2 examples:

VEOLIA:

  • August 2020 Veola launches its bid on Suez. Suez stalls the bid through governance trickery
  • Suez & Veolia contract all investment bankers. Brokers research on both firm goes silent for … 9 months
  • AlphaValue issued 8 updates over the period and goes for a timely loud Buy in October 2021

Download Report on Veolia

RUSAL:

  • Western brokers have shied away from maintaining research since sanctions.
  • AlphaValue initiated the coverage 12 years ago, faced then serious arm bending pressure from the Russian governance, but never stopped tracking the stock including now that Russian issuers are banned/sanctioned.
  • AlphaValue provides a unique independent view made essential as Rusal continues to trade in Hong Kong and remains a unique arbitrage opportunity for positions in Rusal/EN+/Nornickel/ post war Russia.

Download Report on Rusal

There is value in relying on independent, unconflicted, non-execution based research: it is always on as it is exclusively aimed at investors

Subscribe to our blog


Let’s talk
Interested in our research and want to learn more?
AlphaValue Valuation Wise, 26/03/2024
A critical research, focused on corporate governance
Uncover the tumultuous journey of Elekta, the Swedish giant in medical technology, since 2022. Fro...